Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz175.160
Abstract: Chemical or genetic perturbation of the spliceosome function may represent a therapeutic opportunity for Glioblastoma multiforme (GBM) and other cancers. We and others have shown that oncogenic MYC activity causes spliceosome vulnerability and leads to…
read more here.
Keywords:
therapeutic inhibition;
glioblastoma;
inhibition spliceosome;
cbmt therapeutic ... See more keywords